Blake E. Michener

Array ( [id] => 3061074 [patent_doc_number] => 05352446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Method of treating dental caries with monoclonal antibodies against the antigen I and antigen I/II of streptococcus mutans' [patent_app_type] => 1 [patent_app_number] => 7/983273 [patent_app_country] => US [patent_app_date] => 1992-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3066 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352446.pdf [firstpage_image] =>[orig_patent_app_number] => 983273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3084090 [patent_doc_number] => 05284764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-08 [patent_title] => 'Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3' [patent_app_type] => 1 [patent_app_number] => 7/941027 [patent_app_country] => US [patent_app_date] => 1992-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9274 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/284/05284764.pdf [firstpage_image] =>[orig_patent_app_number] => 941027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2979138 [patent_doc_number] => 05250297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-05 [patent_title] => 'Tumor-associated antigen, antibodies, compositions and uses therefor' [patent_app_type] => 1 [patent_app_number] => 7/939384 [patent_app_country] => US [patent_app_date] => 1992-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8587 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/250/05250297.pdf [firstpage_image] =>[orig_patent_app_number] => 939384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2941611 [patent_doc_number] => 05223483 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-29 [patent_title] => 'Cysteine-modified acidic fibroblast growth factor' [patent_app_type] => 1 [patent_app_number] => 7/938310 [patent_app_country] => US [patent_app_date] => 1992-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14724 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/223/05223483.pdf [firstpage_image] =>[orig_patent_app_number] => 938310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3017972 [patent_doc_number] => 05340925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-23 [patent_title] => 'Normal human growth regulatory receptor for TGF-.beta.' [patent_app_type] => 1 [patent_app_number] => 7/900511 [patent_app_country] => US [patent_app_date] => 1992-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10182 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/340/05340925.pdf [firstpage_image] =>[orig_patent_app_number] => 900511 [rel_patent_id] =>[rel_patent_doc_number] =>)